Acquisition Channel Remedy Analytics was acquired by Brown & Brown in 2021, creating a direct access point to a large broker network. This presents a ready-made channel to reach plan sponsors and employers via Brown & Brown's client base, enabling faster penetration of PBM analytics and consulting services. Use this to propose joint go-to-market initiatives, pilots, and revenue-sharing models.

PharmaLogic Advantage The proprietary PharmaLogic analytics platform combines claims data, clinical intelligence, and full-service Rx consulting to optimize pharmacy benefits and reduce spend. Target self-funded employers, health plans, and PBMs seeking measurable ROI on drug spend and population health management; offer data-backed ROI cases and phased implementations.

Mid-Market Focus With a lean 11-50 employee base, Remedy operates as a nimble, high-touch partner ideal for mid-market plan sponsors that require tailored analytics without enterprise vendor overhead. Position as a boutique, fast-moving option within Brown & Brown's ecosystem to win mid-market RFPs and renewals.

Security-Compliance HIPAA-compliant tech stack and PHI handling capabilities should be highlighted when pitching to employers and payers. Emphasize data security, governance, and compliance as a differentiator in competitive bids for PBM analytics and plan implementations.

Pilot and ROI Propose pilot programs with clear success metrics to demonstrate reductions in pharmacy spend and improvements in population health. Use pilots as a springboard to larger contracts within existing broker networks or with new plan sponsors introduced by Brown & Brown.